Figure 7. PAZ inhibits lymphangiogenesis of the CT26-GFP orthotopic-colorectal cancer mouse model. (A) Representative lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) stained in the control tumor (red arrows) and the PAZ group (B; red arrows). (C) The graph shows the corresponding lymphatic vessel density in the control and PAZ group. Magnification 200×; **p<0.01.
